Veradermics, Incorporated (MANE) Receives a Buy from LifeSci Capital

In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on Veradermics, Incorporated, with a price target of $170...

Raccontata damarkets.businessinsider.com